TrialScientific reports2024

SomaLogic proteomics reveals new biomarkers and provides mechanistic, clinical insights into Acetyl coA Carboxylase (ACC) inhibition in Non-alcoholic Steatohepatitis (NASH).

Pitchumani Sivakumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.